Skip to content
biopharmaceutical
EntityQ679692· pop 32· linked from 645 articles

biopharmaceutical

Sign in to save

Also known as biological medical product, biologic medical product

A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living medicines used in cell therapy. Biopharmaceuticals can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living cells or tissues. They (or their precursor

In the Vinony graph

Within Vinony's link graph, biopharmaceutical is referenced by 645 other articles, and connects out to biotechnology, antibody and protein.

It sits within the topics Biopharmaceuticals, Biotechnology and Biotechnology products.

Its subject is documented across 32 Wikipedia language editions.

Wikidata facts

Show 1 more fact
Commons category
Biopharmaceuticals
Sources (2)

via Wikidata · CC0

~17 min read

Encyclopedic overview

16 sections
Contents
  • Major classes
  • Extracted from living systems
  • Produced by recombinant DNA
  • Vaccines
  • Gene therapy
  • Biosimilars
  • Commercialization
  • Large-scale production
  • Transgenics
  • Regulation
  • European Union
  • United States
  • Canada
  • See also
  • References
  • External links

A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living medicines used in cell therapy. Biopharmaceuticals can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. They can be used in both human and animal medicine.

Terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics within the general biopharmaceutical category. The term biologics is often used more restrictively to mean biopharmaceuticals that are produced using recombinant DNA technology. Some regulatory agencies use the terms biological medicinal products or therapeutic biological product to refer specifically to engineered macromolecular products like protein- and nucleic acid-based drugs, distinguishing them from products like blood, blood components, or vaccines, which are usually extracted directly from a biological source. Biopharmaceutics is pharmaceutics that works with biopharmaceuticals. Biopharmacology is the branch of pharmacology that studies biopharmaceuticals. Specialty drugs, a recent classification of pharmaceuticals, are high-cost drugs that are often biologics. The European Medicines Agency uses the term advanced therapy medicinal products (ATMPs) for medicines for human use that are "based on genes, cells, or tissue engineering", including gene therapy medicines, somatic-cell therapy medicines, tissue-engineered medicines, and combinations thereof. Within EMA contexts, the term advanced therapies refers specifically to ATMPs, although that term is rather nonspecific outside those contexts.

Excerpted from Wikipedia’s “biopharmaceutical” article, available under the CC BY-SA 4.0 licence.

Gallery (2)

Connections

Categories